Top Markets
Coin of the day
Soiken Holdings Inc. Soiken Holdings Inc.

Soiken Holdings Inc.

2385
Kedudukan dalam Saham #26792
Founded in 1994 and headquartered in Toyonaka, Japan, Soiken Holdings Inc.... Founded in 1994 and headquartered in Toyonaka, Japan, Soiken Holdings Inc. primarily focuses on the advancement of biomarkers. The company’s operations span a diverse range of health and wellness sectors. It is actively involved in the creation and commercialization of cosmetics and nutritional supplements, alongside the licensing and continued development of biomarker technologies. Soiken also conducts market research and post-market surveillance specifically for dietary supplements. A key area of its work includes the research, development, and sale of functional materials like lactoferrin, as well as pharmaceuticals derived from ascochlorin. Furthermore, Soiken applies its biomarker expertise to perform clinical evaluations for food products. The company extends its services to provide vital support for physician-initiated pharmaceutical clinical research, comprehensive health screenings, and personalized health guidance. It also partners with health insurance societies to offer contracted health guidance, facilitate specialized health check-ups for dependents of the insured, and implement programs designed for diabetes prevention.
Harga Saham
$1.44
Modal Pasaran
$37.72M
Perubahan (1 hari)
1.38%
Perubahan (1 tahun)
20.03%
Negara
JP
Perdagangan Soiken Holdings Inc. (2385)

Kategori

EPS untuk Soiken Holdings Inc. (2385)
EPS setakat 2026 TTM: 0
Menurut laporan kewangan terkini dan harga saham Soiken Holdings Inc., EPS semasa syarikat (TTM) adalah 0. Pada akhir tahun 2026, syarikat mempunyai EPS sebanyak 0 sama dengan EPS tahun 2026 iaitu 0.
Sejarah EPS untuk Soiken Holdings Inc. dari 2026 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
Tidak cukup data untuk tarikh yang disediakan.
EPS untuk syarikat atau pesaing yang serupa
Syarikat EPS Perbezaan EPS Negara
$17.32 -
US
$-7.98 -
US
$27.74 -
NL
$2.98 -
AU
- -
CH